CDE Catalog

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Displaying 126 - 150 of 740
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification CRF Name Copyrighted or trademarked Disease Name Subdisease Name
C02210 Enrolled in study indicator

Indicator of whether the participant/subject was enrolled into the clinical research study

Supplemental Informed Consent and Enrollment General (For all diseases) General (For all diseases)
C02211 Enrolled in study date and time

Date (and time, if applicable and known) the participant/subject is enrolled into the study

Supplemental Screening Log General (For all diseases) General (For all diseases)
C02211 Enrolled in study date and time

Date (and time, if applicable and known) the participant/subject is enrolled into the study

Supplemental Informed Consent and Enrollment General (For all diseases) General (For all diseases)
C02212 Informed consent obtained date and time

Date (and time, if applicable and known) on which the participant/subject (or the legal representative on behalf of the participant/subject) agrees to participate in a protocol, treatment, or other activity by signing an informed consent document

Supplemental Informed Consent and Enrollment General (For all diseases) General (For all diseases)
C02213 Randomized indicator

Indicator of whether the participant/subject was randomly assigned (i.e., by chance not choice) to an intervention/treatment group or control group.

Supplemental Informed Consent and Enrollment General (For all diseases) General (For all diseases)
C02214 Randomized date and time

Date (and time, if applicable and known) the participant/subject is randomly assigned (i.e., by chance not choice) to an intervention/treatment group or control group

Supplemental Informed Consent and Enrollment General (For all diseases) General (For all diseases)
C02215 Study eligibility indicator

Indicator of whether the participant/subject is eligible for participation in the clinical research protocol according to its inclusion and exclusion criteria

Supplemental Inclusion and Exclusion Criteria General (For all diseases) General (For all diseases)
C02216 Exclusion criterion not met number

Exclusion criterion number(s) the participant/subject did not meet

Supplemental Screening Log General (For all diseases) General (For all diseases)
C02216 Exclusion criterion not met number

Exclusion criterion number(s) the participant/subject did not meet

Supplemental Inclusion and Exclusion Criteria General (For all diseases) General (For all diseases)
C02217 Inclusion criterion not met number

Inclusion criterion number(s) the participant/subject did not meet

Supplemental Inclusion and Exclusion Criteria General (For all diseases) General (For all diseases)
C02217 Inclusion criterion not met number

Inclusion criterion number(s) the participant/subject did not meet

Supplemental Screening Log General (For all diseases) General (For all diseases)
C02222 Off study intervention prematurely reason

Primary reason participant/subject discontinued study intervention before planned end of study

Supplemental Study Discontinuation/Completion General (For all diseases) General (For all diseases)
C02300 Adverse event study intervention action taken type

Type of action taken for adverse event in relation to study intervention

Supplemental Adverse Events General (For all diseases) General (For all diseases)
C02301 Adverse event end date and time

Date (and time, if applicable and known) on which the adverse event discontinued/stopped

Supplemental Adverse Events General (For all diseases) General (For all diseases)
C02302 Adverse event other action taken type

Type of action taken due to adverse event other than action taken with study intervention/ treatment

Supplemental Adverse Events General (For all diseases) General (For all diseases)
C02303 Adverse event outcome status

Final status of the participant/subject related to the adverse event

Supplemental Adverse Events General (For all diseases) General (For all diseases)
C02304 Adverse event relatedness scale

Scale of the causality between the treatment modality/intervention and the specific adverse event

Supplemental Adverse Events General (For all diseases) General (For all diseases)
C02305 Adverse event severity scale grade

The grading scale of the severity or intensity of the adverse event

Supplemental Adverse Events General (For all diseases) General (For all diseases)
C02306 Adverse event start date and time

Date (and time, if applicable and known) on which the adverse event was first evident

Supplemental Adverse Events General (For all diseases) General (For all diseases)
C02307 Adverse event verbatim term text

Text that describes the adverse event word for word as described by the participant/subject

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C02307 Adverse event verbatim term text

Text that describes the adverse event word for word as described by the participant/subject

Supplemental Adverse Events General (For all diseases) General (For all diseases)
C02308 Adverse event during study indicator

Indicator of whether the participant/subject experienced any adverse events during the study

Supplemental Adverse Events General (For all diseases) General (For all diseases)
C02309 Serious adverse event indicator

The indicator of whether the adverse event is serious.

Supplemental Adverse Events General (For all diseases) General (For all diseases)
C02309 Serious adverse event indicator

The indicator of whether the adverse event is serious.

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C02310 Adverse event CTCAE low level term name

Text that represents the Common Terminology Criteria for Adverse Events (CTCAE) low level term name for an adverse event

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
Displaying 126 - 150 of 740

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.